In a strategic initiative to improve its market position, our client, a leading innovator in neurotechnology, engaged us to consolidate and enhance its Series B investment strategy, leveraging extensive clinical and market expertise to pave the way for expansive growth and development.
Our recommendations and the corresponding materials we created (e.g. business plan, financial model, pitch deck) supported our client in closing key partnerships and licensing agreements, as well as in closing the fundraising round.